Lyssikatos Joseph P plan to sell securities of Enliven Therapeutics, Inc. under Form 144

Lyssikatos Joseph P filed Form 144 to notify SEC of plan to sell 25000 units of Enliven Therapeutics, Inc. securities around 2026-03-31, with aggregate market value of $914,750.00. The total outstanding units is 59000000.0. The amount planned to be sold represents 0.04% of total outstanding units; Recent transactions in past 3 months include: On 01/08/2026, sold 41302 units for $993437.48; On 01/09/2026, sold 91198 units for $2482579.19; On 01/20/2026, sold 20000 units for $535099.00; On 02/06/2026, sold 5000 units for $145219.10; On 02/18/2026, sold 50000 units for $1317640.00; On 02/19/2026, sold 20000 units for $520217.41; On 02/25/2026, sold 5000 units for $144613.70;